Sphere Fluidics announces Cyto-Mine® Chroma to accelerate and streamline workflows across expanded applications in biotherapeutic discovery and development News Sphere Fluidics announces Cyto-Mine® Chroma to accelerate and streamline workflows across expanded applications in biotherapeutic discovery and development
Sphere Fluidics appoints Dr. Alex Dickinson as Non-Executive Director News Sphere Fluidics appoints Dr. Alex Dickinson as Non-Executive Director
Sphere Fluidics awarded gold accreditation by Investors in People News Sphere Fluidics awarded gold accreditation by Investors in People
Sphere Fluidics Named Life Science Company of the Year at Cambridge Independent Science and Technology Awards 2024 News Sphere Fluidics Named Life Science Company of the Year at Cambridge Independent Science and Technology Awards 2024
Sphere Fluidics launches Cyto-Cellect®PLUS to accelerate cell line development workflows News Sphere Fluidics launches Cyto-Cellect®PLUS to accelerate cell line development workflows
Sphere Fluidics appoints Curtis Nicholson as Director of Sales, EMEA, to support accelerated growth in key markets News Sphere Fluidics appoints Curtis Nicholson as Director of Sales, EMEA, to support accelerated growth in key markets
Sphere Fluidics appoints Dale Levitzke as Chief Executive Officer News Sphere Fluidics appoints Dale Levitzke as Chief Executive Officer
Sphere Fluidics appoints Edward Rayner as Non-Executive Director News Sphere Fluidics appoints Edward Rayner as Non-Executive Director
Sphere Fluidics appoints Dr. Graeme Daniels as Vice President of Sales and Marketing News Sphere Fluidics appoints Dr. Graeme Daniels as Vice President of Sales and Marketing
Sphere Fluidics’ Cyto-Mine® system selected by FairJourney Biologics to advance cell line development workflows News Sphere Fluidics’ Cyto-Mine® system selected by FairJourney Biologics to advance cell line development workflows
